Some research conducted since the intro and subsequent success of a fresh class of cancer medicines called tyrosine kinase inhibitors , which target the abnormal, leukemia-causing proteins BCR-ABL and have improved survival rates, shows that stem cell transplantation might not be necessary for several Ph+ ALL patients. However, clinicians lack a reliable way for predicting disease progression and identifying whether a patient's disease is aggressive enough to warrant a stem cell transplant or if TKI therapy as well as chemotherapy will likely eradicate the disease. Despite the advent of these powerful, targeted cancer therapies, some cancer cells may linger in a individual's body following a primary treatment.Stem cells were ready from a little sample of fat attained from the patient’s belly. Related StoriesNYSCF, CBR collaborate to customize creation of high-quality stem cell linesInner ear canal damage mind warnings from nerve cellsResearchers discover that stem cell treatment may reduce cognitive impairment related to dementia with Lewy bodiesThese fat-derived stem cells are an intriguing new source of stem cells for analysis and treatment reasons. Unlike bone marrow-derived stem cells, ASCs can be acquired in good sized quantities and easily expanded. After developing the stem cells, Dr. Thesleff and co-workers mixed them with a artificial bone grafting material to fill up the skull defects in the four patients. The results had been assessed by computed tomography scans performed the week after medical procedures and at three weeks’ and one year’s follow-up.